Large scale abandonment of foreign enterprises in Zhejiang bidding reaches 60.5%

Source: Mingrui Haohan on March 16, 2015, Zhejiang Pharmaceutical machinery procurement platform issued the notice on the price sorting results of the second batch of products of Zhejiang Pharmaceutical centralized procurement in 2014 and the annex "2014 list of products of Zhejiang Pharmaceutical centralized procurement (the second batch) proposed to be the standard product (I)" Zhejiang bidding opened a new mode to confirm the price of drugs on the Internet, allowing drug companies to confirm the possible price reduction first, and boarded the Zhejiang bidding ship Then start the collection work of the lowest price of relevant products in the country, and the pharmaceutical enterprises are unprepared The bidding price of drugs in Zhejiang Province will become the lowest bidding price of drugs in China, which has completely broken the last hope of pharmaceutical enterprises In fact, when the price combing results of bidding products in Zhejiang were just released, many pharmaceutical companies felt bad, especially some foreign pharmaceutical companies On March 10, the price of the second batch of bids in Zhejiang was sorted out, and the information that foreign enterprises will abandon their bids in a large range was obtained in the communication between the author and the executives of relevant foreign enterprises A well-known foreign enterprise executive told the author that the company held a special meeting to discuss whether to abandon the bid or not There was a lot of debate at the meeting, and the boss finally approved the rejection of the bid So it is now The author compares the information table (2) of the price (decrease) of the second batch of bidding products of Zhejiang Pharmaceutical centralized purchase (2014) released on March 9, and finds that after the large-scale bid abandonment of foreign pharmaceutical enterprises in Hunan's last bidding, the bidding in Zhejiang Province will reproduce the phenomenon of large-scale bid abandonment of foreign pharmaceutical enterprises, with the overall average bid abandonment rate reaching 60.5%, and the highest 92.3% (only one variety of Abbott Pharma is excluded from bidding) Of course, there are also foreign pharmaceutical enterprises with high standard setting rate, such as GSK However, in view of the current situation of GSK, there may be some unspeakable helplessness in it.